0
13

In This Issue
  |  
The American Journal of Psychiatry

October 01, 2003, Vol. 160, No. 10
Get Alert | RSS  
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

In This Issue
In This Issue
Editorial
The Neural Substrates of Affect Impairment in Schizophrenia
Richard D. Lane, M.D., Ph.D.
Reviews and Overviews
A New Anatomical Framework for Neuropsychiatric Disorders and Drug Abuse
Lennart Heimer, M.D.
The “Dreamy State”: John Hughlings-Jackson’s Ideas of Epilepsy and Consciousness
R. Edward Hogan, M.D.; Kitti Kaiboriboon, M.D.
Article
Facial Emotion Recognition in Schizophrenia: Intensity Effects and Error Pattern
Christian G. Kohler, M.D.; Travis H. Turner, B.S.; Warren B. Bilker, Ph.D.; Colleen M. Brensinger, M.S.; Steven J. Siegel, M.D., Ph.D.; Stephen J. Kanes, M.D., Ph.D.; Raquel E. Gur, M.D., Ph.D.; Ruben C. Gur, Ph.D.
Emotions in Unmedicated Patients With Schizophrenia During Evaluation With Positron Emission Tomography
Sergio Paradiso, M.D., Ph.D.; Nancy C. Andreasen, M.D., Ph.D.; Benedicto Crespo-Facorro, M.D.; Daniel S. O’Leary, Ph.D.; G. Leonard Watkins, Ph.D.; Laura L. Boles Ponto, Ph.D.; Richard D. Hichwa, Ph.D.
Impairment of Odor Hedonics in Men With Schizophrenia
Paul J. Moberg, Ph.D.; Steven E. Arnold, M.D.; Richard L. Doty, Ph.D.; Christian Kohler, M.D.; Stephen Kanes, M.D., Ph.D.; Steven Seigel, M.D., Ph.D.; Raquel E. Gur, M.D., Ph.D.; Bruce I. Turetsky, M.D.
Impairment of Olfactory Identification Ability in Individuals at Ultra-High Risk for Psychosis Who Later Develop Schizophrenia
Warrick J. Brewer, Ph.D.; Stephen J. Wood, Ph.D.; Patrick D. McGorry, F.R.A.N.Z.C.P.; Shona M. Francey, Ph.D.; Lisa J. Phillips, M.Psych.(Clin.); Alison R. Yung, F.R.A.N.Z.C.P.; Vicki Anderson, Ph.D.; David L. Copolov, F.R.A.N.Z.C.P.; Bruce Singh, F.R.A.N.Z.C.P.; Dennis Velakoulis, F.R.A.N.Z.C.P.; Christos Pantelis, F.R.A.N.Z.C.P.
Effects of Typical, Atypical, and No Antipsychotic Drugs on Visual Contrast Detection in Schizophrenia
Yue Chen, Ph.D.; Deborah L. Levy, Ph.D.; Summer Sheremata, B.A.; Ken Nakayama, Ph.D.; Steven Matthysse, Ph.D.; Philip S. Holzman, Ph.D.
Neural Correlates of Episodic Encoding and Recognition of Words in Unmedicated Patients During an Acute Episode of Schizophrenia: A Functional MRI Study
Alex Hofer, M.D.; Elisabeth M. Weiss, M.D.; Stefan M. Golaszewski, M.D.; Christian M. Siedentopf; Claudia Brinkhoff, M.D.; Christian Kremser, Ph.D.; Stephan Felber, M.D.; W. Wolfgang Fleischhacker, M.D.
Working Memory Deficit as a Core Neuropsychological Dysfunction in Schizophrenia
Henry Silver, M.B.B.S., B.Med.Sci., D.P.M., F.R.A.N.Z.C.P.; Pablo Feldman, M.D.; Warren Bilker, Ph.D.; Ruben C. Gur, Ph.D.
Racial Disparity in the Use of Atypical Antipsychotic Medications Among Veterans
Laurel A. Copeland, M.P.H., Ph.D.; John E. Zeber, M.H.A.; Marcia Valenstein, M.D., M.S.; Frederic C. Blow, Ph.D.
Mortality and Poststroke Depression: A Placebo-Controlled Trial of Antidepressants
Ricardo E. Jorge, M.D.; Robert G. Robinson, M.D.; Stephan Arndt, Ph.D.; Sergio Starkstein, M.D., Ph.D.
Pharmacogenetics of Antidepressant Medication Intolerance
Greer M. Murphy, Jr., M.D., Ph.D.; Charlotte Kremer, M.D.; Heidi E. Rodrigues, B.A.; Alan F. Schatzberg, M.D.
Greater Availability of Brain Dopamine Transporters in Major Depression Shown by [99mTc]TRODAT-1 SPECT Imaging
David J. Brunswick, Ph.D.; Jay D. Amsterdam, M.D.; P. David Mozley, M.D.; Andrew Newberg, M.D.
Concordant Restoration of Ovarian Function and Mood in Perimenopausal Depression
Robert C. Daly, M.D., M.P.H.; Merry A. Danaceau, R.N.; David R. Rubinow, M.D.; Peter J. Schmidt, M.D.
Abnormal Variability and Distribution of Functional Maps in Autism: An fMRI Study of Visuomotor Learning
Ralph-Axel Müller, Ph.D.; Natalia Kleinhans, B.A.; Nobuko Kemmotsu, B.A.; Karen Pierce, Ph.D.; Eric Courchesne, Ph.D.
Investigation of White Matter Structure in Velocardiofacial Syndrome: A Diffusion Tensor Imaging Study
Naama Barnea-Goraly, M.D.; Vinod Menon, Ph.D.; Ben Krasnow; Alex Ko, B.S.; Allan Reiss, M.D.; Stephan Eliez, M.D.
Relation of Corpus Callosum and Hippocampal Size to Age in Nondemented Adults With Down’s Syndrome
Stefan J. Teipel, M.D.; Mark B. Schapiro, M.D.; Gene E. Alexander, Ph.D.; Jack S. Krasuski, M.D.; Barry Horwitz, Ph.D.; Christian Hoehne; Hans-Jürgen Möller, M.D.; Stanley I. Rapoport, M.D.; Harald Hampel, M.D.
Clinical Case Conference
Progression of Subcortical Ischemic Disease From Vascular Depression to Vascular Dementia
David C. Steffens, M.D., M.H.S.; Warren D. Taylor, M.D.; K. Ranga Rama Krishnan, M.D.
Brief Report
Do Patients With Schizophrenia Consciously Recollect Emotional Events Better Than Neutral Events?
Jean-Marie Danion, M.D.; Mathilde Kazes, M.D., Ph.D.; Caroline Huron, M.D., Ph.D.; Nourdine Karchouni, M.D.
Are Impairments of Action Monitoring and Executive Control True Dissociative Dysfunctions in Patients With Schizophrenia?
And U. Turken, Ph.D.; Patrik Vuilleumier, M.D.; Daniel H. Mathalon, Ph.D., M.D.; Diane Swick, Ph.D.; Judith M. Ford, Ph.D.
Lack of Normal Association Between Cerebellar Volume and Neuropsychological Functions in First-Episode Schizophrenia
Philip R. Szeszko, Ph.D.; Faith Gunning-Dixon, Ph.D.; Robert S. Goldman, Ph.D.; John Bates, Ph.D.; Manzar Ashtari, Ph.D.; Peter J. Snyder, Ph.D.; Jeffrey A. Lieberman, M.D.; Robert M. Bilder
Reduction of Brain Dopamine Concentration With Dietary Tyrosine Plus Phenylalanine Depletion: An [11C]Raclopride PET Study
Andrew J. Montgomery, M.B.B.Chir., M.R.C.P., M.R.C.Psych.; Sarah F.B. McTavish, M.B.B.Chir., D.M., M.R.C.Psych.; Philip J. Cowen, M.B.B.S., M.D., F.R.C.Psych.; Paul M. Grasby, M.B.B.S., M.D., F.R.C.P., M.R.C.Psych.
Increase in Concentration of Waking Salivary Cortisol in Recovered Patients With Depression
Zubin Bhagwagar, M.D., M.R.C.Psych.; Sepehr Hafizi, M.Sc., M.R.C.Psych.; Philip J. Cowen, M.D., F.R.C.Psych.
Resting Regional Cerebral Blood Flow and Gambling Task Performance in Cocaine-Dependent Subjects and Healthy Comparison Subjects
Bryon Adinoff, M.D.; Michael D. Devous, Sr., Ph.D.; Douglas B. Cooper, Ph.D.; Susan E. Best, M.D., Ph.D.; Patricia Chandler, M.D.; Thomas Harris, M.S.; Carole Anne Cervin, M.S.W.; C. Munro Cullum, Ph.D.
Book Forum: Psychopharmacology
The Psychopharmacologists I: Interviews ? The Psychopharmacologists II: Interviews ? The Psychopharmacologists III: Interviews
WILLIAM EDWIN FANN, M.D.
Better Than Prozac: Creating the Next Generation of Psychiatric Drugs
SOLOMON H. SNYDER, M.D.
Book Forum: Consciousness
Neurochemistry of Consciousness: Neurotransmitters in Mind
JAMES A. WILCOX, D.O., PH.D.
Book Forum: Cognitive Impairment
Mild Cognitive Impairment: Aging to Alzheimer’s Disease
MICHAEL R. BIEBER, PH.D.
The Dementias: Diagnosis, Treatment, and Research, 3rd ed.
WILLIAM W. BEATTY, PH.D.
Book Forum: PSYCHOANALYSIS
Conversations at the Frontier of Dreaming
RICHARD D. CHESSICK, M.D., PH.D.
Sexual Orientation and Psychoanalysis: Sexual Science and Clinical Practice
BENJAMIN McCOMMON, M.D.
Images In Neuroscience
Schizophrenia, VI: Treatments
Jeffrey A. Lieberman, M.D.; T. Scott Stroup, M.D., M.P.H.
Images in Psychiatry
Jesse Montgomery Mosher, M.D., 1864–1922
Irwin N. Hassenfeld, M.D.
Introspections
Insight
Richard G. Druss, M.D.
Correction
Correction
Presidential Paper
Presidential Address: Re-Envisioning a Mental Health System for the United States
Paul S. Appelbaum, M.D.
Response to the Presidential Address
Marcia Kraft Goin, M.D., Ph.D.
Paul S. Appelbaum, M.D., 129th President, 2002–2003
Loren H. Roth, M.D.
  |  
Copyright ©
American
Psychiatric
Association